Systems medicine paves the way for improved treatment for leukemia patients
A new individualised systems medicine strategy enables a selection of potentially effective cancer therapies for individual patients. The promising results achieved by applying this strategy to chemoresistant adult acute myeloid leukaemia patients have been recently published A multi-disciplinary team of researchers at the Institute for Molecular Medicine Finland, FIMM, and the Helsinki University Central Hospital […]
